CIK: 0001536054 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 17, 2026
Total Value ($000): $53,326 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| DNLI | DENALI THERAPEUTICS INC | 2,810,732 (-17.6%) | $46,405 (-6.3%) | 87.0% | $33.82 | -50.1% | COM | 24823R105 |
| SANA | SANA BIOTECHNOLOGY INC | 1,220,937 (-33.0%) | $4,969 (-23.1%) | 9.3% | $21.17 | -78.9% | COM | 799566104 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| EGHT | 8X8 INC NEW | 990,580 | $1,952 | 3.7% | $4.02 | -51.0% | COM | 282914100 |